Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide
- PMID: 6176997
- PMCID: PMC345788
- DOI: 10.1073/pnas.79.2.579
Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide
Abstract
On the basis of theoretical considerations, a peptide (H peptide) was synthesized by Hopp and Woods [Hopp, T. P. & Woods, K. R. (1981) Proc. Natl. Acad. Sci. USA 78, 3824---3828]. This peptide contains a sequence of six amino acids postulated to represent the major epitope, or antibody-combining site, of hepatitis B virus surface antigen (HBsAg). We have used passive hemagglutination inhibition with monospecific antibodies against the a, d, and y subdeterminants of this antigen and against human serum albumin to investigate the antigenic specificities on this peptide, and we have found it to contain the HBsAg/a and HBsAg/d but not HBsAg/y or human serum albumin subdeterminants. When the peptide was conjugated onto human erythrocytes and injected into mice, it induced the formation of anti-HBsAg with and without the use of Freund's adjuvant. If anti-HBsAg/a confers immunity to infection with hepatitis B virus, as is generally thought, these findings may permit the development of a synthetic vaccine lacking all unnecessary antigenic determinants.
Similar articles
-
Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. I. T cell fine specificity.J Immunol. 1990 May 1;144(9):3535-43. J Immunol. 1990. PMID: 1691762
-
Synthetic hepatitis B surface antigen peptide vaccine.Adv Exp Med Biol. 1985;185:129-37. doi: 10.1007/978-1-4684-7974-4_8. Adv Exp Med Biol. 1985. PMID: 2416196
-
Immunogenicity of conjugates and micelles of synthetic hepatitis B surface antigen peptides.Intervirology. 1982;18(4):209-13. doi: 10.1159/000149327. Intervirology. 1982. PMID: 6183231
-
Identification of T cell epitopes on hepatitis B surface antigen.Ann Ist Super Sanita. 1991;27(1):37-40. Ann Ist Super Sanita. 1991. PMID: 1720295 Review.
-
A brief overview of the new vaccines against hepatitis B virus infection: immunogenic gene products and peptide analogues of antigenic epitopes.Dev Biol Stand. 1986;63:141-6. Dev Biol Stand. 1986. PMID: 2427376 Review.
Cited by
-
Antibody responses to recombinant and plasma derived hepatitis B vaccines.Br Med J (Clin Res Ed). 1986 Jan 18;292(6514):159-61. doi: 10.1136/bmj.292.6514.159. Br Med J (Clin Res Ed). 1986. PMID: 3080114 Free PMC article. Clinical Trial.
-
Biochemical and immunological characterization of the duck hepatitis B virus envelope proteins.J Virol. 1987 Jul;61(7):2280-5. doi: 10.1128/JVI.61.7.2280-2285.1987. J Virol. 1987. PMID: 3586133 Free PMC article.
-
Hepatitis B virus infection. Current concepts of chronicity and immunity.West J Med. 1984 May;140(5):754-62. West J Med. 1984. PMID: 6328774 Free PMC article. Review.
-
Vaccination against viral hepatitis.Infection. 1982;10(2):55-7. doi: 10.1007/BF01816723. Infection. 1982. PMID: 7095862 No abstract available.
-
Immunogenicity of peptide fusions to hepatitis B virus core antigen.Proc Natl Acad Sci U S A. 1989 Aug;86(16):6283-7. doi: 10.1073/pnas.86.16.6283. Proc Natl Acad Sci U S A. 1989. PMID: 2474830 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases